Industry Insights: MedComms
This weekโs medical communications insights post touches on three compelling topics for writers looking to learn and develop in the world of MedComms.
๐๐ฎ๐น๐ฎ๐ป๐ฐ๐ถ๐ป๐ด ๐ฒ๐ณ๐ณ๐ถ๐ฐ๐ฎ๐ฐ๐ ๐ฎ๐ป๐ฑ ๐๐ฎ๐ณ๐ฒ๐๐ ๐ถ๐ป ๐ฝ๐๐ฏ๐น๐ถ๐ฐ๐ฎ๐๐ถ๐ผ๐ป๐: ๐ฃ๐ผ๐น๐น ๐ฟ๐ฒ๐๐๐น๐๐
A recent poll by the International Society for Medical Publication Professionals (ISMPP) explored how medical publication professionals address a situation where authors emphasise the efficacy of a drug and downplay safety findings. Most respondents supported a collaborative approach that promoted author discussions on how to communicate patient benefits while also highlighting efficacy and safety outcomes. The results suggest that publications professionals value diplomatic dialogue for maintaining scientific balance without direct confrontation.
Link to ISMPP poll results
๐๐ผ๐ ๐๐ผ ๐๐ฟ๐ถ๐๐ฒ ๐ฎ ๐ฐ๐น๐ถ๐ป๐ถ๐ฐ๐ฎ๐น ๐๐๐๐ฑ๐ ๐ฟ๐ฒ๐ฝ๐ผ๐ฟ๐ (๐๐ฆ๐ฅ)?
A recent blog posted by the American Medical Writersโ Association (AMWA) discusses a practical roadmap for medical communicators learning how to write a clinical study report (CSR). The article goes through all the parts of a CSR, from the introduction and study methods to efficacy, safety, discussion, conclusions and references. According to the article, creating a CSR involves a collaborative effort between statisticians, physicians and data managers. New writers should strive to maintain clarity and structure along with technical precision.
Link to AMWA Blog
๐ช๐ต๐ฎ๐ ๐ฑ๐ผ๐ฒ๐ ๐ถ๐ ๐๐ฎ๐ธ๐ฒ ๐๐ผ ๐น๐ฒ๐ฎ๐ฑ ๐ฎ ๐ ๐ฒ๐ฑ๐๐ผ๐บ๐บ๐ ๐ฎ๐ด๐ฒ๐ป๐ฐ๐?
In a recent NetworkPharma.tv episode, Peter Llewellyn spoke with Rick Flemming, founder of UK-based Aspire Scientific, recently named one of the LDC Top 50 Most Ambitious Business Leaders 2025. Flemming discussed the challenges and rewards of leading an independent MedComms agency in a dynamic and competitive MedComms landscape. The speakers highlighted some of the main components of an agencyโs success: quality, culture, and adaptability. According to Flemming, success in MedComms today relies on balancing ambition with authenticity and building teams that value scientific compliance and client trust.
Peter Llewellyn; Rick Flemming
For more industry insights visit elion.nz/insights/.
Want to get in touch? Contact us today at https://elion.nz/get-in-touch/.
